TY - JOUR
T1 - Mid-term follow-up after laparoscopic sleeve gastrectomy in obese adolescents
AU - Raziel, Asnat
AU - Sakran, Nasser
AU - Szold, Amir
AU - Teshuva, Ofir
AU - Krakovsky, Mirit
AU - Rabau, Oded
AU - Goitein, David
PY - 2014/1
Y1 - 2014/1
N2 - Background: Laparoscopic sleeve gastrectomy (LSG) is gaining credibility as a simple and effcient bariatric procedure with low surgical risk. Since surgical treatment for morbid obesity is relatively rare in adolescents, few results have been accumulated so far. Objectives: To prove the safety and efficacy of LSG surgery in an adolescent population methods: Data were prospectively collected regarding adolescent patients undergoing LSG. All patients underwent pre-and postoperative medical and professional evaluation by a multidisciplinary team. results: Between the years 2006 and 2011, 32 adolescents underwent LSG in our center (20 females and 12 males). Mean age was 16.75 years (range 14-18 years), mean weight was 121.88 kg (83-178 kg), and mean body mass index 43.23 (35-54). Thirty-four comorbid conditions were identifed. LSG was the primary bariatric procedure in all the patients. Mean operative time was 60 minutes (range 45-80 min). There were two complications (6.25%): an early staple line leak and a late acute cholecystitis. There were no deaths. Mean percent excess weight loss at 1, 3, 6, 9,12, 24, 36, 48, and 60 months post-surgery was 27.9%, 41.1%, 62.6%, 79.2%, 81.7%, 71%, 75%, 102.9% and 101.6%, respectively. Comorbidities were completely resolved or ameliorated within 1 year following surgery in 82.4% and 17.6%, respectively. conclusions: LSG is feasible and safe in morbidly obese adolescents, achieving effcient weight loss and impressive resolution of comorbidities. Further studies are required to evaluate the long-term results of this procedure as well as its place among other bariatric options.
AB - Background: Laparoscopic sleeve gastrectomy (LSG) is gaining credibility as a simple and effcient bariatric procedure with low surgical risk. Since surgical treatment for morbid obesity is relatively rare in adolescents, few results have been accumulated so far. Objectives: To prove the safety and efficacy of LSG surgery in an adolescent population methods: Data were prospectively collected regarding adolescent patients undergoing LSG. All patients underwent pre-and postoperative medical and professional evaluation by a multidisciplinary team. results: Between the years 2006 and 2011, 32 adolescents underwent LSG in our center (20 females and 12 males). Mean age was 16.75 years (range 14-18 years), mean weight was 121.88 kg (83-178 kg), and mean body mass index 43.23 (35-54). Thirty-four comorbid conditions were identifed. LSG was the primary bariatric procedure in all the patients. Mean operative time was 60 minutes (range 45-80 min). There were two complications (6.25%): an early staple line leak and a late acute cholecystitis. There were no deaths. Mean percent excess weight loss at 1, 3, 6, 9,12, 24, 36, 48, and 60 months post-surgery was 27.9%, 41.1%, 62.6%, 79.2%, 81.7%, 71%, 75%, 102.9% and 101.6%, respectively. Comorbidities were completely resolved or ameliorated within 1 year following surgery in 82.4% and 17.6%, respectively. conclusions: LSG is feasible and safe in morbidly obese adolescents, achieving effcient weight loss and impressive resolution of comorbidities. Further studies are required to evaluate the long-term results of this procedure as well as its place among other bariatric options.
KW - Adolescents
KW - Bariatric surgery
KW - Laparoscopic sleeve gastrectomy (LSG)
KW - Obesity
UR - http://www.scopus.com/inward/record.url?scp=84893083690&partnerID=8YFLogxK
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 24575503
AN - SCOPUS:84893083690
SN - 1565-1088
VL - 16
SP - 37
EP - 41
JO - Israel Medical Association Journal
JF - Israel Medical Association Journal
IS - 1
ER -